{"entity":{"type":"insider","cik":"0001435238","url":"/insider/0001435238","json_url":"/insider/0001435238.json","name":"Engwall K Wyatt","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2008-08-28","last":"2010-06-04","span_basis":"filed_date"},"name_variants":[{"name":"Engwall K Wyatt","source":"filing","n_filings":5,"first_seen":"2008-08-28","last_seen":"2010-06-04"}],"transactions":[{"id":7228620,"accession":"0000795551-10-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-10-000016","line_url":"/filing/0000795551-10-000016#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":1450.0,"total_display":"1,450.00","shares_owned_after":134550.0,"shares_owned_after_display":"134,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-03","filed_date":"2010-06-04","scope":"insider"},{"id":7758621,"accession":"0000795551-10-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-10-000015","line_url":"/filing/0000795551-10-000015#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26200.0,"shares_display":"26,200","price_per_share":1.19,"price_display":"1.19","price_state":"stated","total_value":31178.0,"total_display":"31,178.00","shares_owned_after":133300.0,"shares_owned_after_display":"133,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-01","filed_date":"2010-06-03","scope":"insider"},{"id":7738788,"accession":"0000795551-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-10-000002","line_url":"/filing/0000795551-10-000002#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.346,"price_display":"1.35","price_state":"stated","total_value":67300.0,"total_display":"67,300.00","shares_owned_after":102100.0,"shares_owned_after_display":"102,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-19","filed_date":"2010-02-22","scope":"insider"},{"id":3559028,"accession":"0000795551-08-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-08-000033","line_url":"/filing/0000795551-08-000033#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21100.0,"shares_display":"21,100","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":29751.0,"total_display":"29,751.00","shares_owned_after":47100.0,"shares_owned_after_display":"47,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-06","filed_date":"2008-11-07","scope":"insider"},{"id":3839373,"accession":"0000795551-08-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000795551-08-000029","line_url":"/filing/0000795551-08-000029#line-2","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":33200.0,"total_display":"33,200.00","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-08-28","scope":"insider"},{"id":3839371,"accession":"0000795551-08-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-08-000029","line_url":"/filing/0000795551-08-000029#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001435238","owner_name":"Engwall K Wyatt","owner_url":"/insider/0001435238","role":"Director","officer_title":null,"security_title":"Theragenics Corporation common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":3.3615,"price_display":"3.36","price_state":"stated","total_value":36976.5,"total_display":"36,976.50","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-26","filed_date":"2008-08-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000795551","name":"THERAGENICS CORP","url":"/issuer/0000795551","role":"Director","n_filings":5,"first_seen":"2008-08-28","last_seen":"2010-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001435238","retrieved_at":"2026-08-21T22:43:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}